Frequently asked questions
Find answers to your questions about CAPLYTA
CAPLYTA is a prescription medicine used to treat adults with schizophrenia.Learn more about who CAPLYTA may help
CAPLYTA savings & cost
- Medicare and Medicaid will cover the cost of CAPLYTA for eligible people:
- Medicare Part D: CAPLYTA is covered for 98% of people on Medicare
- Medicaid: CAPLYTA is covered for over 98% of those with Fee-for-Service (FFS)
Covered for over 80% of Commercial Patients.1
Patients with commercial insurance may pay as little as $0 for their first two fills, up to a 30-day supply, and $15 for subsequent fills, up to a 90-day supply with their CAPLYTA Copay Savings Card. Learn more about CAPLYTA insurance coverage
Did you know that there are cost and savings resources for eligible* patients?Learn about a savings offer
*This offer is valid for eligible new or existing patients who are filling a prescription for CAPLYTA. Eligible patients must be at least 18 years old and less than 65 years old, residents of the U.S., excluding Puerto Rico and have a valid prescription for CAPLYTA for a Food & Drug Administration approved indication. This Copay program is valid ONLY for patients with private commercial insurance and NOT valid for prescriptions reimbursed under Medicaid, a Medicare drug benefit plan, TRICARE®, or other federal or state health programs. Offer is not valid for cash paying patients and is only good at participating retail pharmacies. Offer is not transferable, is not insurance, has no cash value, and may not be used in combination with other offers. Void if prohibited by law, taxed, or restricted.
All participants are responsible for reporting the receipt of all Program benefits as required by their insurance provider. No party may seek reimbursement for all or any of the benefit received through this Program. Intra-Cellular Therapies, Inc. reserves the right to rescind, revoke or amend the Program without notice at any time. Additional eligibility criteria apply. Click here for full Eligibility Criteria and Terms and Conditions.
1Data on File. 2021.
The Wholesale Acquisition Cost (WAC), also known as list price, is $49.39 per CAPLYTA capsule.* However, WAC may not reflect the price paid by patients or insurers. Patients with insurance may pay less than the WAC price.Learn more about the cost of CAPLYTA
Did you know that there are cost and savings resources for eligible† patients?Learn more about savings
*Source: AnalySource® 01/07/2022 as reprinted with permission by First Databank, Inc. All rights reserved. ©2022
Weight change on CAPLYTA was similar to placebo in short-term trials. In a long-term study, patients on CAPLYTA for one year had an average weight loss of 7 pounds.
CAPLYTA, like other drugs used to treat schizophrenia, may cause problems with your metabolism, including high blood sugar, diabetes, increased fat (cholesterol and triglyceride) levels in your blood, and weight gain. Your doctor should check your blood sugar, fat levels, and weight before you start and during your treatment with CAPLYTA. Extremely high blood sugar levels can lead to coma or death. Tell your doctor if you have symptoms of high blood sugar, which include feeling very thirsty, hungry, sick to your stomach, weak/tired, or needing to urinate more than usual. Each drug has its own specific risk profile.Learn more
The most common side effects with CAPLYTA are sleepiness (24%) and dry mouth (6%). In clinical trials, sleepiness was predominantly mild. Follow your healthcare provider's direction on when and how to take CAPLYTA. CAPLYTA can cause sleepiness and trouble concentrating. Until you know how CAPLYTA affects you, do not drive, operate heavy machinery, or do other dangerous activities.Learn more
How to take CAPLYTA
Your healthcare provider may tell you what time of day or night is best for you to take CAPLYTA. CAPLYTA can cause sleepiness and trouble concentrating. Until you know how CAPLYTA affects you, do not drive, operate heavy machinery, or do other dangerous activities.Learn more